KEAP1 and cancer: Investigations demonstrated that KEAP1 plays a key role in regulating apoptosis via modulation of the cellular redox balance by targeting NRF2, a transcription factor that is often overexpressed in many human cancers, for proteasome-mediated degradation [26–28].